Pharmafile Logo
Pharmafocus logo
Advanced Search

tenosynovial giant cell tumour

Showing 1 posts of 1 posts found.

MHRA approves Romvimza for tenosynovial giant cell tumour

August 20, 2026
MHRA, Romvimza, tenosynovial giant cell tumour

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Romvimza (vimseltinib) for adults with tenosynovial giant cell tumour (TGCT) …

News
The Gateway to Local Adoption Series

Latest content

MHRA approves Romvimza for tenosynovial giant cell tumour

August 20, 2026

NICE recommends allergy immunotherapy tablets for younger children

August 19, 2026

Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement

August 18, 2026

Panthera opens clinical trial site at Keele University

August 17, 2026

Santen joins inaugural Global Summit for Eye Health as partner

August 14, 2026